Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To CompetitorsMarketWatch Automated·5 hours agoCRBP-3.91%
Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CRBP Stock NewsStockTitan·1 day ago, 01:00 AMCRBP-3.91%
Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily GainsMarketWatch Automated·Aug 12 at 04:21 PMCRBP-3.91%
Corbus Chief Business Officer Nishant Saxena acquires 2,600 shares worth $25,037.44PUBT·Aug 12 at 03:31 PMCRBP-3.91%
Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To CompetitorsMarketWatch Automated·Aug 10 at 04:22 PMCRBP-3.91%
Corbus Q2 FY26 net loss widens to $35.04 million; loss per share increases to $1.81PUBT·Aug 6 at 07:04 AMCRBP-3.91%
Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading DayMarketWatch Automated·Aug 5 at 04:22 PMCRBP-3.91%
